Roxithromycin Market– Regional Analysis
On the basis of region, the global roxithromycin market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold dominant position in the global roxithromycin market during the forecast period. This is owing to increasing government initiatives to prevent antimicrobial resistance and growing awareness for proper use of antibiotics. For instance in March 2015, Health Canada released Federal Action Plan with rules to reduce the risk of antimicrobial resistance in Canada, which includes infection prevention and control, research and innovation in developing antibiotics, and appropriate antimicrobial use for health professionals and the public of Canada.
Asia Pacific is expected to witness significant growth in the global roxithromycin market during the forecast period. This is owing to high infectious disease burden, unregulated sales of antibiotics and poor public health infrastructure, which are leading to increasing use of antibiotics in economies such as India. For instance, according to a report published in the journal The Lancet Infectious Diseases February 2017, Low-Income and Middle-Income Countries (LMICs) of Asia Pacific such as Nepal, Pakistan, India, and Bangladesh witness significant demand for roxithromycin, owing to less stringent policies and easy availability of antibiotics over the counter.
Roxithromycin Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients